Rakuten Securities’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7
Closed -$2K – 1021
2026
Q2
$2K Hold
7
– – ﹤0.01% 655
2026
Q1
$2.08K Sell
7
-1
-13% -$324 ﹤0.01% 613
2025
Q4
$2.43K Buy
+8
New +$2.62K ﹤0.01% 604
2025
Q1
– Sell
-8
Closed -$1.8K – 878
2024
Q4
$1.8K Buy
+8
New +$1.64K ﹤0.01% 574

Other funds holding ONC

Rakuten Securities's ONC Position: Q3 2026 in Review

Rakuten Securities sold out of BeOne Medicines (ONC) in Q3 2026, closing a stake of 7 shares — an estimated $2K sold.

Rakuten Securities first reported a position in ONC in Q4 2024 and held it in 4 quarters. The position peaked at $2.43K in Q4 2025. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Rakuten Securities reported no remaining BeOne Medicines position as of Q3 2026 after selling out during the quarter.
  • Rakuten Securities sold 7 BeOne Medicines shares in Q3 2026, an estimated $2K.
  • Rakuten Securities first reported a position in BeOne Medicines in Q4 2024 and held it in 4 quarters.
  • Rakuten Securities's BeOne Medicines position peaked at $2.43K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.